Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-15

Clinical Trial Update: Simethicone as Part of ERAS in Bariatric Surgery Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the use of simethicone as part of ERAS protocols in bariatric surgery patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Simethicone (simethicone)

Snippet

Sponsor: Madigan Army Medical Center | Conditions: Simethicone, Bariatric Surgery | Phase 4 | Status: RECRUITING